ASO Visual Abstract: Adjuvant Chemotherapy and Survival in MSI-High Stage II and III Colon Cancer: Impact of Histopathological Risk Stratification.

IF 3.5 2区医学 Q2 ONCOLOGY

Annals of Surgical Oncology Pub Date : 2025-10-10 DOI:10.1245/s10434-025-18485-1

Metincan Erkaya, Cigdem Benlice, Salih Karahan, Mustafa Oruc, Volkan Ozben, Bilgi Baca, Emre Gorgun

引用次数: 0

查看原文本刊更多论文

摘要：msi高II期和III期结肠癌的辅助化疗和生存：组织病理学风险分层的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Surgical Oncology 医学-外科

CiteScore

5.90

自引率

10.80%

发文量

1698

审稿时长

2.8 months

期刊介绍： The Annals of Surgical Oncology is the official journal of The Society of Surgical Oncology and is published for the Society by Springer. The Annals publishes original and educational manuscripts about oncology for surgeons from all specialities in academic and community settings.